264 related articles for article (PubMed ID: 32496614)
1. Perioperative management for patients with von Willebrand disease: Defining the optimal approach.
Miesbach W
Eur J Haematol; 2020 Oct; 105(4):365-377. PubMed ID: 32496614
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.
Miesbach W; Berntorp E
Eur J Haematol; 2017 Feb; 98(2):121-127. PubMed ID: 27622750
[TBL] [Abstract][Full Text] [Related]
3. Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.
Peyvandi F; Mamaev A; Wang JD; Stasyshyn O; Timofeeva M; Curry N; Cid AR; Yee TT; Kavakli K; Castaman G; Sytkowski A
J Thromb Haemost; 2019 Jan; 17(1):52-62. PubMed ID: 30362288
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and management of von Willebrand disease].
Higasa S; Tokugawa T; Sawada A
Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
[TBL] [Abstract][Full Text] [Related]
5. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
Franchini M; Mannucci PM
Expert Rev Hematol; 2016 Sep; 9(9):825-30. PubMed ID: 27427955
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery.
Windyga J; von Depka-Prondzinski M;
Thromb Haemost; 2011 Jun; 105(6):1072-9. PubMed ID: 21437358
[TBL] [Abstract][Full Text] [Related]
9. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
Federici AB
Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the diagnosis and management of von Willebrand disease in Italy.
Federici AB; Castaman G; Mannucci PM;
Haemophilia; 2002 Sep; 8(5):607-21. PubMed ID: 12199668
[TBL] [Abstract][Full Text] [Related]
11. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
12. Analysis of current perioperative management with Haemate
Hazendonk HCAM; Heijdra JM; de Jager NCB; Veerman HC; Boender J; van Moort I; Mathôt RAA; Meijer K; Laros-van Gorkom BAP; Eikenboom J; Fijnvandraat K; Leebeek FWG; Cnossen MH;
Haemophilia; 2018 May; 24(3):460-470. PubMed ID: 29573506
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand Disease: Diagnostic Strategies and Treatment Options.
Ng CJ; Di Paola J
Pediatr Clin North Am; 2018 Jun; 65(3):527-541. PubMed ID: 29803281
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
15. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
16. Monitoring Therapy during Treatment of von Willebrand Disease.
Favaloro EJ; Pasalic L; Curnow J
Semin Thromb Hemost; 2017 Apr; 43(3):338-354. PubMed ID: 27472426
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy and delivery in women with von Willebrand disease.
Castaman G; James PD
Eur J Haematol; 2019 Aug; 103(2):73-79. PubMed ID: 31107984
[TBL] [Abstract][Full Text] [Related]
18. Rethinking the diagnosis of von Willebrand disease.
Favaloro EJ
Thromb Res; 2011 Jan; 127 Suppl 2():S17-21. PubMed ID: 21193108
[TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
[TBL] [Abstract][Full Text] [Related]
20. A personalized approach to the management of VWD.
Phua CW; Berntorp E
Transfus Apher Sci; 2019 Oct; 58(5):590-595. PubMed ID: 31466808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
